China Reform Health Management and Services Group Co., Ltd.

Shenzhen Stock Exchange 000503.SZ

China Reform Health Management and Services Group Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 29.41

China Reform Health Management and Services Group Co., Ltd. Price to Sales Ratio (P/S) is 29.41 on January 14, 2025, a -15.90% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

China Reform Health Management and Services Group Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 50.07 on October 23, 2024, which is 70.23% above the current Price to Sales Ratio (P/S).
China Reform Health Management and Services Group Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 18.55 on July 15, 2024, which is -36.92% below the current Price to Sales Ratio (P/S).
China Reform Health Management and Services Group Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 28.26.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shenzhen Stock Exchange: 000503.SZ

China Reform Health Management and Services Group Co., Ltd.

CEO	Mr. Hongquan Yuan
IPO Date	Nov. 30, 1992
Location	China
Headquarters	JunHuaHaiYi Hotel
Employees	1,420
Sector	Finance
Industries Insurance Health Insurance & Plans Hospitals & Clinics

Description

China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It is involved in business that covers 177 medical insurance in 25 provinces. It is also involved in the pharmaceutical and medical business. The company was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. China Reform Health Management and Services Group Co., Ltd. was founded in 1986 and is based in Haikou, China.

Key trends

Past 5 years